Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics

Matthew K. Breitenstein, Gyorgy J Simon, Euijung Ryu, Sebastian M. Armasu, Richard M. Weinshilboum, Liewei Wang, Jyotishman Pathak

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Scopus citations

Abstract

Metformin is a commonly prescribed diabetes medication whose mechanism of action is poorly understood. In this study we utilized EHR-linked biobank data to elucidate the impact of genomic variation on glycemic response to metformin. Our study found significant gene- and SNP-level associations within the beta-2 subunit of the heterotrimeric adenosine monophosphate-activated protein kinase complex. Using EHR phenotypes where were able to add additional clarity to ongoing metformin pharmacogenomic dialogue.

Original languageEnglish (US)
Title of host publicationDigital Healthcare Empowering Europeans - Proceedings of MIE 2015
EditorsRonald Cornet, Lacramioara Stoicu-Tivadar, Ronald Cornet, Carlos Luis Parra Calderon, Stig Kjaer Andersen, Alexander Horbst, Mira Hercigonja-Szekeres
PublisherIOS Press
Pages914-918
Number of pages5
ISBN (Electronic)9781614995111
DOIs
StatePublished - 2015
Event26th Medical Informatics in Europe Conference, MIE 2015 - Madrid, Spain
Duration: May 27 2015May 29 2015

Publication series

NameStudies in Health Technology and Informatics
Volume210
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Other

Other26th Medical Informatics in Europe Conference, MIE 2015
CountrySpain
CityMadrid
Period5/27/155/29/15

Keywords

  • Biobank
  • Electronic Health Records
  • Metformin
  • Pharmacogenomics
  • Type 2 Diabetes Mellitus

Fingerprint Dive into the research topics of 'Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics'. Together they form a unique fingerprint.

Cite this